TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+32.01%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$288M
AUM Growth
+$288M
(+42%)
Cap. Flow
+$54.3M
Cap. Flow
% of AUM
18.81%
Top 10 Holdings %
Top 10 Hldgs %
62.41%
Holding
37
New
13
Increased
8
Reduced
6
Closed
9
Top Buys
| 1 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$19.9M |
| 2 |
Merck
MRK
|
$15.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$14.9M |
| 4 |
Baxter International
BAX
|
$13.6M |
| 5 |
Merus
MRUS
|
$12.9M |
Top Sells
| 1 |
AbbVie
ABBV
|
$26M |
| 2 |
GE HealthCare
GEHC
|
$13.3M |
| 3 |
Biogen
BIIB
|
$11.9M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$11.8M |
| 5 |
Praxis Precision Medicines
PRAX
|
$8.68M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $31.3M | 10.84% | 2,216,188 +421,853 | +24% | +$5.95M |
|
|
AVDL
2
Avadel Pharmaceuticals
AVDL
$1.43B
| $20.1M | 6.97% | 1,189,511 +349,578 | +42% | +$5.9M |
|
|
SILK
3
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $19.9M | 6.88% | +1,083,605 | New | +$19.9M |
|
4
Natera
NTRA
$23.1B
| $17.4M | 6.03% | 190,114 +48,267 | +34% | +$4.41M |
|
5
Ascendis Pharma
ASND
$11.8B
| $17M | 5.91% | 112,670 +13,120 | +13% | +$1.98M |
|
6
Legend Biotech
LEGN
$6.41B
| $15.9M | 5.52% | 283,773 +181,558 | +178% | +$10.2M |
|
|
7
Merck
MRK
$210B
| $15.7M | 5.45% | +119,200 | New | +$15.7M |
|
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $14.9M | 5.16% | +35,598 | New | +$14.9M |
|
9
Madrigal Pharmaceuticals
MDGL
$9.76B
| $14.2M | 4.94% | 53,355 +27,831 | +109% | +$7.43M |
|
|
10
Baxter International
BAX
$12.7B
| $13.6M | 4.71% | +317,566 | New | +$13.6M |
|
|
11
Merus
MRUS
$4.98B
| $12.9M | 4.47% | +286,322 | New | +$12.9M |
|
12
Tandem Diabetes Care
TNDM
$845M
| $11.6M | 4.01% | +326,506 | New | +$11.6M |
|
13
argenx
ARGX
$43.6B
| $11M | 3.82% | 27,981 +3,799 | +16% | +$1.5M |
|
14
Xenon Pharmaceuticals
XENE
$2.98B
| $8.93M | 3.1% | 207,465 -18,099 | -8% | -$779K |
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.25M | 2.86% | 8,567 -7,445 | -46% | -$7.17M |
|
16
Axsome Therapeutics
AXSM
$6.05B
| $8.2M | 2.84% | 102,711 -28,027 | -21% | -$2.24M |
|
|
17
Praxis Precision Medicines
PRAX
$958M
| $6.5M | 2.25% | 106,494 -142,267 | -57% | -$8.68M |
|
18
Exact Sciences
EXAS
$8.98B
| $6.22M | 2.16% | +90,000 | New | +$6.22M |
|
19
Lyra Therapeutics
LYRA
$11.5M
| $6.09M | 2.11% | +978,793 | New | +$6.09M |
|
20
Astria Therapeutics
ATXS
$349M
| $5.2M | 1.8% | 369,549 -173,396 | -32% | -$2.44M |
|
21
Inspire Medical Systems
INSP
$2.77B
| $5.06M | 1.76% | +23,566 | New | +$5.06M |
|
|
ALPN
22
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $4.78M | 1.66% | +120,687 | New | +$4.78M |
|
23
Arcturus Therapeutics
ARCT
$462M
| $4.69M | 1.63% | 138,927 +28,457 | +26% | +$961K |
|
24
Arcutis Biotherapeutics
ARQT
$1.86B
| $4.46M | 1.55% | +449,694 | New | +$4.46M |
|
25
MindMed
MNMD
$676M
| $3.57M | 1.24% | +379,596 | New | +$3.57M |
|